The trial enrolled 80 women aged 45 and older diagnosed with breast cancer who were about to start neoadjuvant chemotherapy (NCT), a type of chemo given before surgery to shrink tumors. Participants were randomly assigned to receive either 2,000 IU of vitamin D daily or a placebo for six months, during their chemotherapy treatment.
Similar Posts
This Little-Known Bioactive Helps Protect Against Dementia, Study Shows
From a general health standpoint, citicoline has been found to help maintain cognitive function during normal…
These Meal Delivery Services Offer Balanced Meals To Help With Weight Loss
What our editor says: “If you have weight loss goals, certain dietary preferences, or simply want…
List of Whole Foods to Stock Your Kitchen
As moms, we set the tone in our house for our family, and that includes teaching…
AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial…
What An OB/GYN Wants You To Know About Birth Control & Emotional Eating
Registered Dietitian Nutritionist Molly Knudsen, M.S., RDN is a Registered Dietician Nutritionist with a bachelor’s degree…
Bot vs. Bot: Why Healthcare AI Progress Might Be Stuck
Healthcare is in the middle of an AI gold rush, with investors, providers and payers pouring…
